Page - (000423) - in Biomedical Chemistry: Current Trends and Developments

parasympathetic nervous system 1 Parkinson 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 particle size 1, 2, 3 passive targeting 1, 2, 3, 4, 5 patient 1, 2, 3, 4, 5 penicillin 1, 2, 3, 4 peptide 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 Peptidomimetic 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 P-glycoprotein 1, 2, 3, 4, 5, 6 Pharmacokinetics 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 phosphates 1, 2, 3, 4 plasma 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 plasmodium 1, 2, 3, 4, 5, 6 polarised 1 β–position 1 potassium 1, 2, 3, 4, 5 precision 1, 2, 3, 4 preclinical 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 pre-clinical development 1 primaquine 1, 2, 3, 4, 5, 6 prodrug 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 protonation 1, 2, 3, 4 protons 1, 2 proline 1, 2, 3, 4, 5, 6, 7 pseudopeptides 1, 2, 3, 4 quality control 1, 2, 3 quinidine 1 quinine 1, 2, 3, 4, 5, 6 quinoline 1, 2, 3 racemates 1 Racemic mixtures 1 radical 1, 2, 3, 4, 5, 6, 7 rats 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 reactive oxygen species 1, 2, 3, 4 redox reactions 1